Credit Suisse Ag Akero Therapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 46,547 shares of AKRO stock, worth $1.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

46,547

Previous 40,384 15.26%

Holding current value

$1.34 Million

Previous $942,000 24.73%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$17.76 - $31.18 $109,454 - $192,162	6,163 Added 15.26%	46,547 $1.18 Million
Q4 2023 Feb 08, 2024	SELL	$11.38 - $50.33 $31,989 - $141,477	-2,811 Reduced 6.51%	40,384 $942,000
Q3 2023 Nov 13, 2023	SELL	$41.19 - $52.25 $305,794 - $387,904	-7,424 Reduced 14.67%	43,195 $2.18 Million
Q2 2023 Aug 11, 2023	BUY	$36.89 - $56.88 $831,426 - $1.28 Million	22,538 Added 80.26%	50,619 $2.36 Million
Q1 2023 May 10, 2023	BUY	$37.27 - $50.24 $53,743 - $72,446	1,442 Added 5.41%	28,081 $1.07 Million
Q4 2022 Feb 13, 2023	BUY	$33.44 - $54.8 $456,890 - $748,732	13,663 Added 105.29%	26,639 $1.46 Million
Q3 2022 Nov 10, 2022	BUY	$10.15 - $34.05 $1,512 - $5,073	149 Added 1.16%	12,976 $441,000
Q2 2022 Aug 12, 2022	BUY	$8.0 - $15.01 $13,192 - $24,751	1,649 Added 14.75%	12,827 $122,000
Q1 2022 May 16, 2022	BUY	$12.97 - $22.26 $4,409 - $7,568	340 Added 3.14%	11,178 $159,000
Q4 2021 Feb 14, 2022	SELL	$19.87 - $26.24 $392,114 - $517,820	-19,734 Reduced 64.55%	10,838 $229,000
Q3 2021 Nov 12, 2021	BUY	$18.65 - $25.46 $377,382 - $515,183	20,235 Added 195.75%	30,572 $682,000
Q2 2021 Aug 16, 2021	SELL	$24.81 - $32.35 $21,783 - $28,403	-878 Reduced 7.83%	10,337 $256,000
Q1 2021 May 14, 2021	SELL	$24.04 - $34.19 $415,603 - $591,076	-17,288 Reduced 60.65%	11,215 $326,000
Q4 2020 Feb 12, 2021	BUY	$25.12 - $29.89 $467,834 - $556,671	18,624 Added 188.52%	28,503 $735,000
Q3 2020 Nov 13, 2020	BUY	$30.79 - $39.92 $304,174 - $394,369	9,879 New	9,879 $304,000

Others Institutions Holding AKRO

# of Institutions

168

Shares Held

72.7M

Call Options Held

178K

Put Options Held

164K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.34B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account